Two biologics studied for multiple myeloma
User rating: 3.8 / 5 after 4 vote(s)
U.S. medical scientists report investigating two novel biologics for their potential benefit to multiple myeloma patients.
Full story »
Full story »
Full story »
PhysOrg Forum
Video
Editorials
Free Magazines
Newsletter
Goto Archive
Suggest a story idea
Send feedback
